Home
Friday, August 08, 2008
Best Practice Database Supports Bio-Pharma Product Launch
Comtex
CHAPEL HILL, N.C., Aug 08, 2008 /PRNewswire via COMTEX/ ----Bio-Pharma executives are increasingly finding value in the research products and services offered by Best Practices, LLC and in particular in use of the on-demand benchmark repository known as the Best Practice Database ( http://www.BestPracticeDatabase.com ). Although documents from the database may be accessed and downloaded individually, many commercial and operations leaders have come to find outstanding value in membership to the database which not only provides full access to all content as needed, but also includes services such as new research alerts, invitations to participate in topical new studies and ongoing advisory services to address research needs.
A series of six case study analogs recently published to the database review various aspects of product launch, providing unique perspectives for understanding the strategies and tactics utilized by top bio-pharma companies to address commercial issues surrounding their products. One study, "Requip Case Study: Life Cycle Management -- Reinvigorating a Mature Brand," reviews the strategy and tactics utilized by GlaxoSmithKline for the Parkinson's indicated product, Requip/Adartrel, to manage the life and commercial success of the brand through re-branding for treatment of Restless Leg Syndrome (RLS).
For a complimentary summary from this case study, found in the Best Practice Database, "Requip Case Study: Life Cycle Management -- Reinvigorating a Mature Brand," click on the following link: http://www3.best-in-class.com/dr329.htm .
Key topic areas in the research include: -- Coordinated Marketing Efforts -- Patient Advocacy -- Disease Awareness -- Condition Branding -- Market Preparation -- Disease State Critical Success Factors -- Managing Disease Perception -- Educating the Market on New Mechanism of Action -- Direct to Consumer (DTC) Communications Metrics included in this report are: -- Lifecycle Timeline -- Brand Revenues -- Disease Area Support Contributions
For more information on this study or the Best Practice Database, contact Robert Naylor at rnaylor@best-in-class.com or (919) 767-9244. Interested parties may sign-up for a customized tour of the database via the following URL: http://www3.best-in-class.com/dw212.htm .
ABOUT BEST PRACTICES, LLC
Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more than 15 years, our highly credentialed research staff has conducted primary research exclusively for our Fortune 500 client base.
SOURCE Best Practices, LLC
http://www.best-in-class.com
Copyright (C) 2008 PR Newswire. All rights reserved
FOX Translator
No data currently available.
No data currently available.
No, it's not a dance craze. Contago is a condition of supply and demand, essentially a fancy word to say that prices for items, typically commodities, are cheaper now than they would be at some point down the line.
Anything that¿s sold in the futures market can be in a case of contango. Futures are exactly that: a contract to buy an item or asset at a price in the future. This is the case with oil, with traders buying and selling contracts to acquire a barrel of oil in months down the line. When a market is in contango, spot prices, or the price of a commodity if you were to buy it right now, are lower than forward prices.
Why is that important? Well, it usually tells you the supply of a given commodity is plentiful (since, according to Economics 101, a large supply usually leads to cheap prices).
Incidentally, if you think contango is a mouthful, its opposite condition is known by the equally tongue-tying term backwardation.
